J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer
Important Target For Novel NK Immune Checkpoint Inhibitor Identified!
BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma
Hannover International Neuroscience Institute,INI
Women's Beauty Learn The "Three Keys"
Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma
